SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-012057
Filing Date
2021-11-12
Accepted
2021-11-12 12:01:45
Documents
1
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 12236
  Complete submission text file 0001654954-21-012057.txt   13912
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LOWSLEY HOUSE 133 HEADLEY ROAD LIPHOOK X0 GU30 7PU
Business Address
Breen Michael Martin (Reporting) CIK: 0001863633 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40023 | Film No.: 211401770